Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma

par Jian He, Rui Gao, Mei Meng, Miao Yu, Chengrong Liu, Jingquan Li, Yizhi Song, Hui Wang
Publié 2021

ASSESSMENT OF STROMAL AND INTRA-EPITHELIAL TUMOR INFILTRATING LYMPHOCYTES IN COLORECTAL CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY

par Amna Ameer, Farhan Akhtar, Hafeez Ud Din, Rabia Ahmed
Publié 2021

Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas

par Dina Mohamed El Samman, Manal Mohamed El Mahdy, Hala Sobhy Cousha, Zeinab Abd El Rahman Kamar, Khaled Abdel Karim Mohamed, Hoda Hassan Abou Gabal
Publié 2021

The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer

par Laura García-Estevez, Laura García-Estevez, Laura García-Estevez, Silvia González-Martínez, Silvia González-Martínez, Gema Moreno-Bueno, Gema Moreno-Bueno, Gema Moreno-Bueno
Publié 2021

Gradual Histopathologic Changes During Development of Colorectal Cancer

par Vahid Nejati, Jamileh Abedi, Maedeh Vakili Saatloo, Maryam Koohsoltani, Rahim Hobbenaghi, Amir Tukmachi
Publié 2019

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]

par Luo M, Lin Y, Liang R, Li Y, Ge L
Publié 2021

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment

par Luo M, Lin Y, Liang R, Li Y, Ge L
Publié 2021

Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters

par Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
Publié 2021

Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients

par Jikun Feng, Jianxia Li, Xinjian Huang, Jiarong Yi, Haoming Wu, Xuxiazi Zou, Wenjing Zhong, Xi Wang
Publié 2021

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer

par Jin Hong, Weiwei Rui, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Publié 2021

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth

par Eva Reijmen, Sven De Mey, Helena Van Damme, Helena Van Damme, Kirsten De Ridder, Thierry Gevaert, Emmy De Blay, Luc Bouwens, Christine Collen, Lore Decoster, Marijke De Couck, Marijke De Couck, Damya Laoui, Damya Laoui, Jacques De Grève, Mark De Ridder, Yori Gidron, Cleo Goyvaerts
Publié 2021

Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow

par Huynh Cao, Do Hyun Kim, Ashley Howard, Hector Moz, Samiksha Wasnik, David J. Baylink, Chien-Shing Chen, Mark E Reeves, Saied Mirshahidi, Jeffrey Xiao, Olivia Francis, Guido Marcucci, Yi Xu
Publié 2021

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

par Jesse Lopes da Silva, Lucas Zanetti de Albuquerque, Fabiana Resende Rodrigues, Guilherme Gomes de Mesquita, Guilherme Gomes de Mesquita, Priscila Valverde Fernandes, Luiz Claudio Santos Thuler, Andreia Cristina de Melo
Publié 2021

Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells

par Yi-Hsin Liang, Kuo-Hsing Chen, Jia-Huei Tsai, Yung-Ming Cheng, Chang-Cheng Lee, Chiu-Hwa Kao, Kuang-Yu Chan, Yeh-Ting Chen, Wen-Ling Hsu, Kun-Huei Yeh
Publié 2021

Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer

par Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ying-Shu You, William Tzu-Liang Chen, K. S. Clifford Chao
Publié 2018

The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer

par Dmitrii V. Tabakov, Tatiana N. Zabotina, Naily V. Chanturia, Elena N. Zakharova, Igor K. Vorotnikov, Vladimir Yu. Selchuk, Victor V. Sokolovskiy, Alexander V. Petrovsky
Publié 2021

Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma–Carcinoma Pathway Progression

par Zhang Y, Zhang X, Jin Z, Chen H, Zhang C, Wang W, Jing J, Pan W
Publié 2021

The identification of tumor-infiltrating lymphocytes in patients with stomach cancer

par Gulnoz G. Khakimova, Yana A. Bozhchenko, Tatyana N. Zabotina, Alexey A. Tryakin
Publié 2021

Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density

par Xu Y, Lou X, Liang Y, Zhang S, Yang S, Chen Q, Xu Z, Zhao M, Li Z, Zhao K, Liu Z
Publié 2021

Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

par Somasundaram A, Burns TF
Publié 2017